This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Allergy Therapeutics's Median PS Value or its related term are showing as below:
AGYTF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.06 Med: 1.38 Max: 2.43
Current: 0.14
During the past 13 years, the highest Price to Median PS Value of Allergy Therapeutics was 2.43. The lowest was 0.06. And the median was 1.38.
AGYTF's Price-to-Median-PS-Value is ranked better than 97.41% of 501
companies
in the Drug Manufacturers industry
Industry Median: 0.8
vs AGYTF: 0.14
Allergy Therapeutics Median PS Value Historical Data
The historical data trend for Allergy Therapeutics's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Allergy Therapeutics's Median PS Value
For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allergy Therapeutics's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Allergy Therapeutics's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.6415.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Allergy Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.053.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allergy Therapeutics (OTCPK:AGYTF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Allergy Therapeutics's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.02
/
0.14
=
0.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allergy Therapeutics Median PS Value Related Terms
Thank you for viewing the detailed overview of Allergy Therapeutics's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Allergy Therapeutics (Allergy Therapeutics) Business Description
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AGYTF has been successfully added to your 